RecruitingNot ApplicableNCT06880510

The Locus Coeruleus, Norepinephrine and Cognitive Aging


Sponsor

Cornell University

Enrollment

150 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The locus coeruleus (LC) has recently been identified as one of the earliest sites of damage in AD with pathological lesions appearing as early as the mid-20s. In this study, the investigators use a variety of techniques including structural MRI, functional MRI, pupillometry, and transcutaneous vagus nerve stimulation to assess the health of the LC and its relation to easily measurable peripheral variables.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at the locus coeruleus — a small brain region that produces norepinephrine (a key brain chemical) — and how it changes with age and contributes to cognitive decline (thinking and memory problems). Using MRI brain scans and cognitive testing, researchers aim to understand why some people age better cognitively than others. **You may be eligible if:** - You are 18 or older - You can speak and understand English - Your hearing and vision are normal or correctable - You are comfortable using a touchscreen, keyboard, and mouse - You are willing and able to have an MRI scan at the Cornell MRI Facility **You may NOT be eligible if:** - You have metal implants or other factors that make MRI unsafe (e.g., pacemakers, certain implants) - You are claustrophobic to a degree that prevents MRI - You cannot complete the cognitive or computer-based assessments - You have a neurological condition that would confound the study results Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEt-VNS transcutaneous auricular vagus nerve stimulator

An investigator will clip the the transcutaneous auricular vagus nerve stimulator (taVNS) to the outer ear, and apply electrical current to modulate the activity of the vagus nerve. During this process, the investigator will monitor pupil size and heart rate to determine whether either of these variables is affected by vagus nerve stimulation.


Locations(1)

Cornell University

Ithaca, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06880510


Related Trials